Product Information
NALTREXONE 50 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $1.1375 per EA under NDC 16729008110. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Aug 17, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729008110
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NALTREXONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091205FDA Approved
8/17/2011
TE Code
AB
On Market Since
1/18/2012
Pharmacological Classes
Price Statistics
The NADAC for NALTREXONE 50 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 13.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1375 per EA |
|---|---|
| All-time high | $1.2957 (Nov 12, 2025) |
| All-time low | $0.6309 (Feb 22, 2023) |
| 52-week high | $1.2957 |
| 52-week low | $1.1375 |
| Median price | $0.8156 |
| Average price | $0.8736 |
| Largest weekly change | +23.3% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Accord Healthcare Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naltrexone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NALTREXONE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NALTREXONE 50 MG TABLET, manufactured by Accord Healthcare Inc., is $1.1375 per EA (NDC 16729008110), effective Sep 30, 2026.
How has the price of NALTREXONE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for NALTREXONE 50 MG TABLET has risen 13.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NALTREXONE 50 MG TABLET?
Since Nov 28, 2013, the NADAC for NALTREXONE 50 MG TABLET has ranged from a low of $0.6309 (Feb 22, 2023) to a high of $1.2957 (Nov 12, 2025), with a median of $0.8156 per EA.
Are there cheaper alternatives to NALTREXONE 50 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NALTREXONE 50 MG TABLET, is $0.8886 per EA — about 22% below NALTREXONE 50 MG TABLET.
Who manufactures NALTREXONE 50 MG TABLET?
NALTREXONE 50 MG TABLET (NDC 16729008110) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.